Tag:
NIH
Latest Headlines
Latest Headlines
Search goes on for HIV vaccine after NIH trial nixed
When Gilead Sciences' ($GLD) Truvada was approved as an HIV preventative last year, it was hailed as a historic event. It was the first time an HIV drug had been approved to stave off HIV infection, rather than treat those who had already contracted the virus.
UPDATED: Obama seeks revolutionary brain discoveries on a budget
President Barack Obama plans to roll out a highly anticipated brain mapping project today, providing details about the ambitious initiative to uncover mysteries about complex brain functions that could lead to new therapies for Alzheimer's and Parkinson's diseases.
Tiny wireless sensor moves brain research forward
Researchers have been testing a compact, self-contained sensor that has been used to record and transmit brain activity data for more than a year in animal studies.
Researchers, biopharma companies protest budget cuts at FDA, NIH
With big budget cutbacks under way at both the NIH and the FDA, drug developers as well as researchers and patient groups are scrambling to lobby the government to protect grants as well as keep all of the industry's user fees committed to drug reviews.
Sequester cuts come down heavy on scientific, medical research
Deep, across-the-board federal spending cuts--totaling $85 billion--are set to go into effect today after Congress and President Barack Obama failed to come to an agreement on a deficit reduction plan. The sequester cuts will no doubt have an impact on scientific and medical research, adding to several years' worth of small cuts and freezes to federal grant funding at government agencies like the National Institutes of Health.
As sequestration dawns, FDA supporters scramble to ease woes on drug reviews
Grappling with major government budget cuts, the FDA is seeking remedies to preserve programs of vital interest to pharma and device companies. Now that sequestration has arrived today, power brokers in the White House and Congress could hold the keys to keeping the agency on track.
Is it too soon to quit on Nabi's nicotine vaccine?
A new study showed a glimmer of hope for a troubled nicotine vaccine after a series of clinical trial setbacks, as investigators hold out hope for new weapons against smoking, a leading cause of deadly cancers, lethal lung disease and other fatal ailments. Yet evidence from the latest study could be too scant to win over some skeptics.
Lonza inks $6.9M stem cell supply deal with NIH
CMO Lonza has signed a three-year, $6.9 million agreement with NIH's Center for Regenerative Medicine, signing on to supply stem cells for research purposes.
NIH-funded researchers test Shigella vaccine
National Institutes of Health-funded researchers aim to put a stop to Shigella, an illness found most commonly in children, with two related vaccine candidates.
NIH pours $900K into Parkinson's biomarker research
NIH is looping Emory's Rollins School of Public Health into its Parkinson's Disease Biomarker Program, pledging $900,000 to a research team aiming to discover new ways of identifying the ailment.
